Table 2

Main baseline patient characteristics

Age (years)MaleDiabetesSmokerHTNLipids*ACSPrevious MILesion locationStent diameter (mm)Total stent length (mm)Radial approach
LMCALADLCxRCA
Bio-Resort63.9±10.81702 (73%)421 (18%)695 (30%)1104 (47%)913 (39%)1633 (70%)457 (20%)1.6% (76)40.4% (1883)23.4% (1091)32.8% (1530)2.8±0.631.045.4%
BIOFLOW II62.7±10.4348 (77%)128 (28%)124 (27%)350 (77%)315 (70%)93 (22.2)121 (26%)0.2% (1)43.0% (217)25.3% (128)31.3% (158)2.8±0.521.8NR
BIOFLOW IV64.7±9.6426 (74%)176 (30%)135 (23%)432 (75%)397 (69%)125 (22%)176 (31%)0.3%
(2)
39.8%
(261)
25.2%
(165)
34.7%
(277)
3.0±0.418.466.3%
BIOFLOW V64.5±10.4988 (74%)466 (35%)311 (23%)1050 (79%)1065 (80%)677 (51%)353 (26%)49.6% (662)31.9% (425)39.4% (525)2.6±0.527.7NR
BIOFLOW VI59.1±8.5302 (68%)118 (27%)156 (35%)245 (56%)177 (40%)345 (78%)48 (11%)0.0% (0)51.9% (262)19.2% (97)28.3% (143)3.16±0.4829.595.6%
BIONYX64.0±111894 (76%)510 (21%)741 (31%)1262 (52%)1114 (46%)1765 (71%)400 (16%)1.5% (47)41.4% (1340)23.8% (772)33.1% (1071)NR30.073.1%
BIOSCIENCE66±11.51634 (77%)486 (23%)609 (29%)1434 (68%)1428 (67%)1131 (53%)427 (20%)1.8% (56)42.3% (1328)22.6% (711)30.5% (957)3.0±0.426.7NR
BIOSTEMI63±11.8990 (76%)155 (12%)544 (42%)578 (44%)606 (47%)1300 (100%)51 (4%)1.4% (19)51.7% (673)21.5% (280)49.8% (648)3.1732.9NR
ORIENT65±11266 (72%)96 (26%)101 (27%)243 (65%)200 (54%)176 (47%)NR4.8% (25)46.6% (243)24.8% (129)23.8% (124)2.99±0.4637.7NR
PRISON IV63±10259 (78%)108 (32%)65 (20%)302 (92%)316 (96%)35 (11%)100 (30%)29.7% (98)15.4% (15)54.8% (181)3.2±0.452.430.9%
  • Data are N (%) or N (±SD).

  • *Lipids—dyslipidaemia.

  • ACS, acute coronary syndrome; HTN, hypertension; LAD, left anterior descending artery; LCx, Circumflex; LMCA, left main coronary artery; MI, myocardial infarction; RCA, right coronary artery.